Akamis Bio Limited
Records under this name other than the patents Akamis Bio Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Showing 1 to 7 of 7 · Back to Akamis Bio Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,849,945 | Oncolytic Adenovirus Encoding a B7 Protein or Active Fragment Formerly held In force · High confidence | In force | High confidence | |
| US 7,510,868 | Chimeric Adenoviruses for Use in Cancer Treatment Term ended Term ended Apr 21, 2026 · High confidence | Term ended | Term ended Apr 21, 2026 | High confidence |
| US 8,158,599 | Chimeric Adenoviruses for Use in Cancer Treatment Term ended Ended no later than Oct 6, 2025 · Medium confidence | Term ended | Ended no later than Oct 6, 2025 | Medium confidence |
| US 9,034,344 | Chimeric Adenoviruses for Use in Cancer Treatment Term ended Term ended Sep 10, 2025 · High confidence | Term ended | Term ended Sep 10, 2025 | High confidence |
| US 9,115,337 | Chimeric Adenoviruses for Use in Cancer Treatment Term ended Term ended Sep 10, 2025 · High confidence | Term ended | Term ended Sep 10, 2025 | High confidence |
| US 8,765,463 | Chimeric Adenoviruses for Use in Cancer Treatment Term ended Ended no later than May 24, 2025 · Medium confidence | Term ended | Ended no later than May 24, 2025 | Medium confidence |
| US 9,234,185 | Chimeric Adenoviruses for Use in Cancer Treatment Term ended Term ended May 24, 2025 · High confidence | Term ended | Term ended May 24, 2025 | High confidence |